Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

BACKGROUND AND OBJECTIVE: Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP) treated with antifibrotic agents, which has been previously poorly documented. METHODS: We retrospectively examined...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Pulm Med
Autori principali: Kawamura, Kodai, Ichikado, Kazuya, Ichiyasu, Hidenori, Anan, Keisuke, Yasuda, Yuko, Suga, Moritaka, Sakagami, Takuro
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593518/
https://ncbi.nlm.nih.gov/pubmed/31238929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0880-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi